William Hoffman, Director at Inari Medical, Inc. (NARI), sold 400,000 shares at $61.27 ($24.2M) on 2025-01-06, disclosed to the SEC on 2025-01-08.
Scheduled sale ($24.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.13 | 141,075 | $8.5M | 35.1% |
| 2 | $60.13 | 141,075 | $8.5M | 35.1% |
| 3 | $61.27 | 58,925 | $3.6M | 14.9% |
| 4 | $61.27 | 58,925 | $3.6M | 14.9% |
| Total | $60.47 avg | 400,000 | $24.2M | 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |
| NARI | SELL | 2024-09-18 | $3.7M | — | Filing → |